Damora Therapeutics, Inc. (DMRA) — Strategic Asset Allocation Index
Damora Therapeutics, Inc. (DMRA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $32.33 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Damora Therapeutics, Inc. to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Damora Therapeutics, Inc. Strategic Asset Allocation Index (2021–2023)
This chart shows how Damora Therapeutics, Inc.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $32.33 Million USD. See Damora Therapeutics, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Damora Therapeutics, Inc. (2021–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Damora Therapeutics, Inc. from 2021 to 2023, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Damora Therapeutics, Inc..
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $32.33 Million | ▼ -9.4 pp |
| 2022 | 9.4% | $5.83 Million | $- | $5.83 Million | $61.75 Million | ▲ +1.7 pp |
| 2021 | 7.7% | $9.05 Million | $- | $9.05 Million | $117.22 Million | — |